SCREEN(SH:688053)2024-04-29 08:42Financial Performance - The company's operating revenue for Q1 2024 was ¥28,670,179.99, representing a decrease of 55.01% compared to the same period last year[4]. - The net profit attributable to shareholders was ¥4,571,726.52, down 80.47% year-on-year[4]. - The net profit after deducting non-recurring gains and losses was ¥3,357,116.13, a decline of 85.60% compared to the previous year[5]. - The basic and diluted earnings per share were both ¥0.05, reflecting a decrease of 78.26% year-on-year[5]. - Total operating revenue for Q1 2024 was CNY 28,670,179.99, a decrease of 55.1% compared to CNY 63,719,430.62 in Q1 2023[22]. - Net profit for Q1 2024 was CNY 3,276,392.33, a decline of 86.0% from CNY 23,413,414.12 in Q1 2023[23]. - Earnings per share for Q1 2024 was CNY 0.05, compared to CNY 0.23 in Q1 2023[23]. Cash Flow and Liquidity - The net cash flow from operating activities increased significantly by 473.04%, amounting to ¥23,596,244.96[5]. - The company's cash and cash equivalents decreased from RMB 308.30 million on December 31, 2023, to RMB 238.36 million as of March 31, 2024, representing a decline of approximately 22.67%[16]. - The ending cash and cash equivalents balance decreased to $238,364,031.05 from $608,619,985.53, a drop of 60.9% year-over-year[26]. - The company reported a cash inflow from other operating activities of $2,274,775.83, up from $655,295.64, representing a growth of 247.5%[25]. - The net cash flow from operating activities reached $23,596,244.96, significantly up from $4,117,741.59 in the same period last year, marking a growth of 471.5%[25]. - The net cash flow from investing activities was -$82,319,678.08, a decline from $442,920,394.48 in Q1 2023, indicating a significant shift in investment strategy[26]. - The net cash flow from financing activities was -$11,212,636.27, worsening from -$5,938,257.76 in Q1 2023, indicating increased financial strain[26]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,833,421,594.41, a decrease of 0.49% from the end of the previous year[5]. - Total assets as of Q1 2024 amounted to CNY 1,833,421,594.41, slightly down from CNY 1,842,516,345.64 in the previous quarter[18]. - Total liabilities for Q1 2024 were CNY 110,659,026.08, a decrease of 3.0% from CNY 115,023,655.78 in the previous quarter[18]. - The total current assets decreased from RMB 1.34 billion on December 31, 2023, to RMB 1.27 billion as of March 31, 2024, reflecting a decrease of about 5.37%[16]. Operational Challenges - The company faced a decline in revenue primarily due to a temporary adjustment in the downstream military industry, leading to delayed military orders[7]. - The increase in unit operating costs contributed to the decline in gross profit margin[7]. - The company invested in equipment and facility leasing to expand testing capacity, resulting in increased depreciation costs[8]. Shareholder and Management Changes - As of March 31, 2024, the company has repurchased a total of 824,481 shares, accounting for 0.82% of the total share capital, with a total expenditure of approximately RMB 37.99 million[14]. - The company has appointed Ma Weidong as the acting chairman and legal representative during the absence of the actual controller Zhang Ya, who is currently under detention[13]. - There are no changes in the top 10 shareholders or the top 10 unrestricted shareholders due to the transfer of shares for margin trading[13]. Future Outlook - The company has not disclosed any new product developments or technological advancements in the current report[12]. - The company has not reported any significant market expansion or acquisition strategies in the current quarter[12]. - The company plans to focus on new product development and market expansion strategies in the upcoming quarters, although specific details were not provided in the content[24].